Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Methotrexate 5mg/2ml solution for injection vials (Pfizer Ltd) |
| BNF code | 0801030P0AAAIAI |
| Virtual Medicinal Product | Methotrexate 5mg/2ml solution for injection vials |
| Name | Methotrexate 5mg/2ml solution for injection vials |
| Date of name applicability | 5 Jul 2004 |
| Previous name | Methotrexate 2.5mg/ml injection 2ml vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Intrathecal |
| Licensed Route | |
| Licenced route | Intraarterial |
| Licensed Route | |
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Methotrexate 5mg/2ml solution for injection vials (Pfizer Ltd) 5 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.